Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Wolverine World Wide to Hold

Argus Research Downgrades Wolverine World Wide to Hold

Argus Research analyst John Staszak downgrades Wolverine World Wide (NYSE:WWW) from Buy to Hold.

byBenzinga Newsdesk

August 18, 2022

1 minute read

Argus Research analyst John Staszak downgrades Wolverine World Wide (NYSE:WWW) from Buy to Hold.

Morgan Stanley Maintains Underweight on W.W. Grainger, Lowers Price Target to $421

By Benzinga Newsdesk

July 15, 1:09 PM

Morgan Stanley analyst Joshua Pokrzywinski maintains W.W. Grainger (NYSE:GWW) with a Underweight and lowers the price target from $449 to $421.

GWW

Alibaba Group Holding Q2 EPS $1.82 Beats $1.64 Estimate, Sales $29.12B Miss $29.45B Estimate

By Benzinga Newsdesk

November 17, 7:40 AM

Alibaba Group Holding (NYSE:BABA) reported quarterly earnings of $1.82 per share which beat the analyst consensus estimate of $1.64 by 10.98 percent. This is a 4.6 percent increase over earnings of $1.74 per share from

BABA

FDA
News

Walgreens Boots Alliance Plans To Get Certified For FDA Abortion Pill Program

By Michael Horton

January 4, 6:24 PM

-Bloomberg

WBA

Armada Hoffler Properties Reiterates FY2024 FFO Outlook $1.21-1.27 vs $1.24 Est

By Benzinga Newsdesk

May 9, 6:07 AM

Outlook The Company maintained its 2024 full-year Normalized FFO guidance range at the Company's previous guidance range of $1.21 to $1.27 per diluted share. The following table updates the Company's

AHH

Argus Research Downgrades Wolverine World Wide to Hold

Related Posts

Morgan Stanley Maintains Underweight on W.W. Grainger, Lowers Price Target to $421

Alibaba Group Holding Q2 EPS $1.82 Beats $1.64 Estimate, Sales $29.12B Miss $29.45B Estimate

Walgreens Boots Alliance Plans To Get Certified For FDA Abortion Pill Program

Armada Hoffler Properties Reiterates FY2024 FFO Outlook $1.21-1.27 vs $1.24 Est